Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Significance of Membrane Transport01:44

The Significance of Membrane Transport

28.0K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
28.0K
The Early Endosome: Endocytosis of Transferrin01:28

The Early Endosome: Endocytosis of Transferrin

3.3K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beam quality control technology for solid-state lasers based on thermal effects.

Optics express·2023
Same author

Mycophenolate mofetil versus cyclophosphamide plus in patients with connective tissue disease-associated interstitial lung disease: Efficacy and safety analysis.

Open medicine (Warsaw, Poland)·2023
Same author

The relationship between serum creatinine/cystatin C ratio and mortality in hypertensive patients.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2023
Same author

Gli1 marks a sentinel muscle stem cell population for muscle regeneration.

Nature communications·2023
Same author

MpADC, an L-aspartate-α-decarboxylase, from Myzus persicae, that enables production of β-alanine with high yield by whole-cell enzymatic catalysis.

Biotechnology for biofuels and bioproducts·2023
Same author

Predicting Positive Repeat Prostate Biopsy Outcomes: Comparison of Machine Learning Approaches to Identify Key Parameters and Optimal Algorithms.

Archivos espanoles de urologia·2023

Related Experiment Video

Updated: Jul 29, 2025

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

351

Ferroportin1 in the brain.

Zhong-Ming Qian1, Wei Li1, Qian Guo2

  • 1Department of Neurology, Affiliated Hospital of Nantong University, and Institute of Translational and Precision Medicine, Nantong University, 19 Qi Xiu Road, Nantong, Jiangsu China 226019.

Ageing Research Reviews
|May 26, 2023
PubMed
Summary
This summary is machine-generated.

Reduced expression of ferroportin 1 (Fpn1), an iron exporter, may increase brain iron levels in neurodegenerative diseases (NDs). This study reviews Fpn1

Keywords:
Ferroportin 1 (Fpn1)Hepcidin-dependent and -independent pathwaysIron effluxIron metabolism proteinsNeurodegenerative disorders

More Related Videos

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.1K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

982

Related Experiment Videos

Last Updated: Jul 29, 2025

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

351
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.1K
Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
09:21

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

982

Area of Science:

  • Neurobiology
  • Neurodegenerative Diseases
  • Iron Metabolism

Background:

  • Neurodegenerative diseases (NDs) are characterized by abnormal brain iron accumulation.
  • The precise mechanisms driving this iron dysregulation remain incompletely understood.
  • Disrupted expression of iron-metabolizing proteins is implicated in elevated brain iron.

Purpose of the Study:

  • To review the current understanding of ferroportin 1 (Fpn1) expression in the brain.
  • To explore the potential role of reduced Fpn1 in iron enhancement in NDs.
  • To discuss Fpn1 regulation and its implications for Alzheimer's disease (AD) and Parkinson's disease (PD).

Main Methods:

  • Literature review of studies on Fpn1 expression in mammalian brain and cell lines.
  • Analysis of research linking Fpn1 to iron importers (LfR, p97) and NDs.
  • Discussion of hepcidin-dependent and -independent pathways affecting Fpn1.

Main Results:

  • Increased expression of iron importers (LfR in PD, p97 in AD) is observed.
  • Decreased expression of the iron exporter Fpn1 is suggested to contribute to brain iron overload in NDs.
  • Fpn1 reduction can be modulated by hepcidin-dependent and -independent mechanisms.

Conclusions:

  • Reduced Fpn1 expression is a potential key factor in brain iron elevation in NDs.
  • Understanding Fpn1 regulation is crucial for developing therapeutic strategies for AD, PD, and other NDs.
  • Further research into Fpn1's role can elucidate mechanisms of neurodegeneration.